lundi 25 septembre 2017

Onco Actu du 25 septembre 2017

1. Biologie

Metastatic breast cancer affects bone mineral before spreading [Cornell University]

2.6 Etiologie - Environnement

France reaffirms opposition to license renewal for weedkiller glyphosate [Reuters]

3.3 Prévention - Vaccins

The HPV Vaccine Gains Ground Among U.S. Teenagers [NY Times]

4.2 Dép., diag. & prono. - Génome

DNA start-ups attract cash from venture funds [Financial Times]

5.12.1 Immunothérapies - partenariats

AbbVie pairs up another ADC cancer drug with Bristol-Myers Squibb's Opdivo [FierceBiotech]

AbbVie and Bristol-Myers Squibb Announce Clinical Research Collaboration to Evaluate a Therapeutic Regimen in Advanced Solid Tumors [AbbVie]

5.12.6 Immunothérapies - AMM

Japan Ministry of Health, Labor and Welfare Approves Opdivo (nivolumab) for the Treatment of Patients with Unresectable Advanced or Recurrent Gastric Cancer Which Has Progressed After Chemotherapy [BMS]

Bristol-Myers Squibb’s Opdivo® (nivolumab) Receives FDA Approval for the Treatment of Hepatocellular Carcinoma Patients Previously Treated with Sorafenib [BMS]

Roche receives EU approval of TECENTRIQ® (atezolizumab) in a specific type of metastatic lung cancer and two types of metastatic bladder cancer [Roche]

FDA grants accelerated approval to pembrolizumab for advanced gastric cancer [FDA]

Roche cancer immunotherapy Tecentriq wins EU approval [Reuters]

5.12.8 Immunothérapies - Economie

Gene Therapy Holds Great Promise, But Big Price [Express Scripts]

How to cover Novartis’ $475K CAR-T drug Kymriah? A ‘new payment model’ is the only way, Express Scripts says [FiercePharma]

5.3 Traitements - FDA, EMA, NICE...

FDA Disputes Article Highlighting Lackluster Oversight of Postmarketing Studies [RAPS]

5.3.4 Traitements - AMM (FDA, EMA)

FDA Expands Approval of Fulvestrant for Advanced Breast Cancer [NCI]

6. Lutte contre les cancers

To advance medicine’s future, the NIH tries to win the trust of communities mistreated in the past [STAT]

6.1 Observation

Forgoing Chemotherapy Linked to Worse Survival in Older Patients With Advanced Colon Cancer Who had Dementia [AACR]

6.4 Médico-éco

Richard Smith: Schopenhauer, the Economist, and cancer [BMJ Blogs]

6.6 Publications

Few authors choose anonymous peer review, massive study of Nature journals shows [Science]